Purchase Order HHSN261201700091A
Ended Awarded Last action
- Contract number
- HHSN261201700091A
- Awardee
-
Mayo Clinic UEI Y2K4F9RPRRG7
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $70,000
Award facts
- Opportunity
-
- N02CP7270176 Solicitation number
- Procurement of Biosamples for Analysis of suspected endometrial cancer and precursors Award Notice · Posted Sep 4, 2017
- Contract value 100% obligated
- $70,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Rochester, MN 55905, USA
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute awarded a purchase order to Mayo Clinic for $70,000 on September 22, 2017, for procurement of biosamples for analysis of suspected endometrial cancer and precursors. The order is firm fixed price with no set-aside designation. Performance occurs in Rochester, Minnesota, and the order completion date is September 21, 2018.
Quick answers
Who was awarded contract HHSN261201700091A?
HHSN261201700091A was awarded to Mayo Clinic by National Cancer Institute (National Institutes of Health) on September 22, 2017.
How much is contract HHSN261201700091A worth?
The government has obligated $70,000 on HHSN261201700091A.
Was contract HHSN261201700091A competed?
The extent of competition for HHSN261201700091A was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award